SOPHiA GENETICS has expanded its relationship with Laboratorio Curie, a leading laboratory located in the capital city of Paraguay. Laboratorio Curie is now live on the SOPHiA DDM Platform and will use the technology to deploy a new test that will identify BRCA gene mutations. Discoveries made using this test aim to enable Laboratorio Curie to support the increased use of precision medicine for hereditary cancers within the country.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SOPH:
